These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7074620)

  • 1. Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine.
    Cameron RG; Imaida K; Tsuda H; Ito N
    Cancer Res; 1982 Jun; 42(6):2426-8. PubMed ID: 7074620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotive effect of primary and secondary bile acids on the induction of gamma-glutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats.
    Tsuda H; Masui T; Imaida K; Fukushima S; Ito N
    Gan; 1984 Oct; 75(10):871-5. PubMed ID: 6150873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
    Shirai T; Imaida K; Ohshima M; Fukushima S; Lee MS; King CM; Ito N
    Jpn J Cancer Res; 1985 Jan; 76(1):16-9. PubMed ID: 2857671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogens as promoters of hepatic neoplasia.
    Wanless IR; Medline A
    Lab Invest; 1982 Mar; 46(3):313-20. PubMed ID: 6278220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
    Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
    J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on initiating activity of secondary bile acids for rat hepatocarcinogenesis].
    Kitazawa S
    Hokkaido Igaku Zasshi; 1993 Jan; 68(1):110-20. PubMed ID: 8095246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
    Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
    Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol.
    Yager JD; Campbell HA; Longnecker DS; Roebuck BD; Benoit MC
    Cancer Res; 1984 Sep; 44(9):3862-9. PubMed ID: 6744303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules.
    Chen ZY; Liu YF; He CY; White CC; Eaton DL
    Cancer Res; 1994 May; 54(10):2622-9. PubMed ID: 7909493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of cytochrome(s) P450 2B1/2 by phenobarbital in hepatic hyperplastic nodules induced by aflatoxin B1 or diethylnitrosamine plus 2-acetylaminofluorene in male F344 rats.
    Chen ZY; Eaton DL
    Toxicol Appl Pharmacol; 1991 Oct; 111(1):132-44. PubMed ID: 1949030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
    Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
    Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver.
    Tsuda H; Hasegawa R; Imaida K; Masui T; Moore MA; Ito N
    Gan; 1984 Oct; 75(10):876-83. PubMed ID: 6150874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the pituitary in tumor promotion with ethinyl estradiol in rat liver.
    Hallstrom IP; Liao DZ; Assefaw-Redda Y; Ohlson LC; Sahlin L; Eneroth P; Eriksson LC; Gustafsson JA; Blanck A
    Hepatology; 1996 Oct; 24(4):849-54. PubMed ID: 8855187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver.
    Ito N; Tsuda H; Hasegawa R; Imaida K
    Environ Health Perspect; 1983 Apr; 50():131-8. PubMed ID: 6191977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continued development of hepatic gamma-glutamyltranspeptidase-positive foci upon withdrawal of 17 alpha-ethynylestradiol in diethylnitrosamine-initiated rats.
    Campen DB; Sloop TC; Maronpot RR; Lucier GW
    Cancer Res; 1987 May; 47(9):2328-33. PubMed ID: 2882836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
    Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
    Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
    Hirose M; Futakuchi M; Tanaka H; Orita SI; Ito T; Miki T; Shirai T
    Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats.
    Tanaka T; Kojima T; Kawamori T; Yoshimi N; Mori H
    Cancer Res; 1993 Jun; 53(12):2775-9. PubMed ID: 8504418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
    Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.